133 related articles for article (PubMed ID: 10027651)
1. The S-acyl-2-thioethyl pronucleotide approach applied to acyclovir: part I. Synthesis and in vitro anti-hepatitis B virus activity of bis(S-acyl-2-thioethyl)phosphotriester derivatives of acyclovir.
Périgaud C; Gosselin G; Girardet JL; Korba BE; Imbach JL
Antiviral Res; 1999 Jan; 40(3):167-78. PubMed ID: 10027651
[TBL] [Abstract][Full Text] [Related]
2. The SATE pronucleotide approach applied to acyclovir: part II. Effects of bis(SATE)phosphotriester derivatives of acyclovir on duck hepatitis B virus replication in vitro and in vivo.
Hantz O; Périgaud C; Borel C; Jamard C; Zoulim F; Trépo C; Imbach JL; Gosselin G
Antiviral Res; 1999 Jan; 40(3):179-87. PubMed ID: 10027652
[TBL] [Abstract][Full Text] [Related]
3. Bis-S-acyl-2-thioethyl (SATE)-bearing monophosphate prodrug of beta-L-FD4C as potent anti-HBV agent.
Li X; Carmichael E; Feng M; King I; Doyle TW; Chen SH
Bioorg Med Chem Lett; 1998 Jan; 8(1):57-62. PubMed ID: 9871628
[TBL] [Abstract][Full Text] [Related]
4. New insights regarding the potential of the pronucleotide approach in antiviral chemotherapy.
Gosselin G; Girardet JL; Périgaud C; Benzaria S; Lefebvre I; Schlienger N; Pompon A; Imbach JL
Acta Biochim Pol; 1996; 43(1):196-208. PubMed ID: 8790724
[TBL] [Abstract][Full Text] [Related]
5. Antiviral activity and intracellular metabolism of bis(tButylSATE) phosphotriester of beta-L-2',3'dideoxyadenosine, a potent inhibitor of HIV and HBV replication.
Placidi L; Faraj A; Loi AG; Pierra C; Egron D; Cretton-Scott E; Gosseli G; Périgaud C; Martin LT; Schinazi RF; Imbach JL; el Kouni MH; Bryant ML; Sommadossi JP
Antivir Chem Chemother; 2001 Mar; 12(2):99-108. PubMed ID: 11527047
[TBL] [Abstract][Full Text] [Related]
6. SATE pronucleotide approaches: an overview.
Peyrottes S; Egron D; Lefebvre I; Gosselin G; Imbach JL; Périgaud C
Mini Rev Med Chem; 2004 May; 4(4):395-408. PubMed ID: 15134542
[TBL] [Abstract][Full Text] [Related]
7. Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC).
Das K; Xiong X; Yang H; Westland CE; Gibbs CS; Sarafianos SG; Arnold E
J Virol; 2001 May; 75(10):4771-9. PubMed ID: 11312349
[TBL] [Abstract][Full Text] [Related]
8. S-acyl-2-thioethyl (SATE) pronucleotides are potent inhibitors of HIV-1 replication in T-lymphoid cells cross-resistant to deoxycytidine and thymidine analogs.
Gröschel B; Cinatl J; Périgaud C; Gosselin G; Imbach JL; Doerr HW; Cinatl J
Antiviral Res; 2002 Feb; 53(2):143-52. PubMed ID: 11750940
[TBL] [Abstract][Full Text] [Related]
9. Use of the hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (-)-beta-2',3'-dideoxy-3'-thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA.
Delaney WE; Miller TG; Isom HC
Antimicrob Agents Chemother; 1999 Aug; 43(8):2017-26. PubMed ID: 10428929
[TBL] [Abstract][Full Text] [Related]
10. Generation of stable cell lines expressing Lamivudine-resistant hepatitis B virus for antiviral-compound screening.
Walters KA; Tipples GA; Allen MI; Condreay LD; Addison WR; Tyrrell L
Antimicrob Agents Chemother; 2003 Jun; 47(6):1936-42. PubMed ID: 12760870
[TBL] [Abstract][Full Text] [Related]
11. Amidate Prodrugs of Deoxythreosyl Nucleoside Phosphonates as Dual Inhibitors of HIV and HBV Replication.
Liu C; Dumbre SG; Pannecouque C; Huang C; Ptak RG; Murray MG; De Jonghe S; Herdewijn P
J Med Chem; 2016 Oct; 59(20):9513-9531. PubMed ID: 27748590
[TBL] [Abstract][Full Text] [Related]
12. Penciclovir is a selective inhibitor of hepatitis B virus replication in cultured human hepatoblastoma cells.
Korba BE; Boyd MR
Antimicrob Agents Chemother; 1996 May; 40(5):1282-4. PubMed ID: 8723485
[TBL] [Abstract][Full Text] [Related]
13. In vitro antihepadnaviral activities of combinations of penciclovir, lamivudine, and adefovir.
Colledge D; Civitico G; Locarnini S; Shaw T
Antimicrob Agents Chemother; 2000 Mar; 44(3):551-60. PubMed ID: 10681317
[TBL] [Abstract][Full Text] [Related]
14. Phosphatidyl-2',3'-dideoxy-3'-thiacytidine: synthesis and antiviral activity in hepatitis B-and HIV-1-infected cells.
Xie H; Voronkov M; Liotta DC; Korba BA; Schinazi RF; Richman DD; Hostetler KY
Antiviral Res; 1995 Oct; 28(2):113-20. PubMed ID: 8585765
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and evaluation of novel oxazaphosphorine prodrugs of 9-(2-phosphonomethoxyethyl)adenine (PMEA, adefovir) as potent HBV inhibitors.
Lu P; Liu J; Wang Y; Chen X; Yang Y; Ji R
Bioorg Med Chem Lett; 2009 Dec; 19(24):6918-21. PubMed ID: 19889538
[TBL] [Abstract][Full Text] [Related]
16. Characterization of novel human hepatoma cell lines with stable hepatitis B virus secretion for evaluating new compounds against lamivudine- and penciclovir-resistant virus.
Fu L; Cheng YC
Antimicrob Agents Chemother; 2000 Dec; 44(12):3402-7. PubMed ID: 11083647
[TBL] [Abstract][Full Text] [Related]
17. Ester prodrugs of acyclic nucleoside thiophosphonates compared to phosphonates: synthesis, antiviral activity and decomposition study.
Roux L; Priet S; Payrot N; Weck C; Fournier M; Zoulim F; Balzarini J; Canard B; Alvarez K
Eur J Med Chem; 2013 May; 63():869-81. PubMed ID: 23603046
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antiviral evaluation of some beta-L-2', 3'-dideoxy-5-chloropyrimidine nucleosides and pronucleotides.
Pierra C; Imbach JL; De Clercq E; Balzarini J; Van Aerschot A; Herdewijn P; Faraj A; Loi AG; Sommadossi JP; Gosselin G
Antiviral Res; 2000 Mar; 45(3):169-83. PubMed ID: 10771081
[TBL] [Abstract][Full Text] [Related]
19. Robustaflavone, a potential non-nucleoside anti-hepatitis B agent.
Zembower DE; Lin YM; Flavin MT; Chen FC; Korba BE
Antiviral Res; 1998 Aug; 39(2):81-8. PubMed ID: 9806485
[TBL] [Abstract][Full Text] [Related]
20. [Anti-hepatitis B virus effects of lamivudine and other five drugs in vitro].
Cao H; Tao P
Zhonghua Yi Xue Za Zhi; 2001 Aug; 81(16):1004-7. PubMed ID: 11718074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
